title: Treatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in rats.
abstract: Oral doses of norfloxacin (80 mg/kg of body weight per day) and ciprofloxacin (25 and 80 mg/kg/day) and intramuscular doses of teicoplanin (5 mg/kg/day), all administered once a day for 10 days, were evaluated as a means of preventing encrusted cystitis caused by Corynebacterium group D2. Zinc disks dipped into a 24-h broth culture of these microorganisms were inserted into the bladders of female Wistar rats, and treatment was started 14 days after bacterial challenge. The appearance of encrusted cystitis was directly related to a documented urinary tract infection by these coryneforms (71.7 and 0% for rats with positive and negative urine cultures, respectively). All rats that died between days 18 to 43 after bacterial challenge presented very severe encrusted cystitis, which was prevented by teicoplanin and high doses of ciprofloxacin. Rats surviving up to day 44 after bacterial challenge were sacrificed; they presented a lower incidence of encrusted cystitis which was also less severe, with teicoplanin and a high dose of ciprofloxacin being more active in reducing the rate of positive cultures (78.8 and 65.7% reduction, respectively). All antibiotics and doses used were active in vivo at preventing encrusted cystitis by Corynebacterium group D2, but the best therapeutic effect was obtained with teicoplanin.
authors.affiliation: Department of Microbiology, Universidad Autónoma de Madrid, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Soriano
authors.forename: J L
authors.initials: JL
authors.lastname: Rodriguez-Tudela
authors.forename: C
authors.initials: C
authors.lastname: Castilla
authors.forename: P
authors.initials: P
authors.lastname: Avilés
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D002939:Ciprofloxacin / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D003354:Corynebacterium Infections / Q000188:drug therapy*; D003556:Cystitis / Q000188:drug therapy*; D005260:Female; D006020:Glycopeptides / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D009643:Norfloxacin / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D051381:Rats; D011919:Rats, Inbred Strains; D017334:Teicoplanin
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D002939:Ciprofloxacin; D017334:Teicoplanin; D009643:Norfloxacin